The trademark application IGEMIE was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on July 15, 2019, and it was registered by office on October 22, 2019 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on August 25, 2020. Change of name and address of the trademark registration was recorded on May 4, 2022. Change of name and address of the trademark registration was recorded on May 16, 2022.